Venue: COBIS, Ole Maaløes Vej 3, Copenhagen N
Time: 14:30 - 17:30
The Biotech & MedTech industry are increasingly complex from a commercial, regulatory, and clinical perspective. Join us to learn about essential development steps to take and get inspiration about how to integrate these requirements into your lifecycle planning for increased success and sustainable growth.
Quotes from previous workshops with Charlotte Piester:
“I feel the talk was a great starting point for market access plan development and really contributed to our development and our ability to present a mature value offer”, CEO TigerQ
“Inspirational, valuable and a good cookbook for our continued work”, CTO GPX Medical
This inspirational talk will help you become even more successful in your product development planning. Linked to numerous real-life cases on how life science companies successfully developed, it will provide applicable ideas and lessons learned. Additionally, related to the recently published marketing book by Sinua partners, there will be an interactive overview of a new Biotech and MedTech business model that embraces value and evidence-based communication from the start via a clear, straightforward, cost-efficient and structured business model.
The workshop aims to create meaningful dialogue on:
There will be plenty of time for questions and discussions.
Charlotte Bruun Piester: Charlotte has over 25 years of experience within the Life Science industry, which includes substantial insights from working within public and private healthcare markets around the globe. She has held executive positions in global companies with responsibilities within S&M, pipeline management, business development, and headed global business units. Through this blend of experiences, she has developed a unique understanding and strong track-record in leading, heading and driving life science businesses and organizations. Her educational background is a combination of clinical and business experience and she holds a Master of Business Administration. Charlotte has been part of the build-up of four companies, her latest is Sinua Partners ApS. In addition, she sits on several boards and acts as chairperson for several life science companies.